Interim Safety and Efficacy of Voxelotor in Children Aged 2 to <4 years With Sickle Cell Disease

Speaker(s)

• 

  Beng Fuh, MD

  Professor of Pediatrics
  East Carolina University, Brody School of Medicine
  Greenville, North Carolina, United States

  Slides

First Author(s)

• CN

  Cynthia Norris, MD

  Medical Director, Acute Hematology Care Unit
  Children's Hospital of Philadelphia, Philadelphia, PA, USA
  Philadelphia, Pennsylvania, United States

Corresponding Author(s)

• CN

  Cynthia Norris, MD

  Medical Director, Acute Hematology Care Unit
  Children's Hospital of Philadelphia, Philadelphia, PA, USA
  Philadelphia, Pennsylvania, United States

Author(s)

• CN

  Cynthia Norris, MD

  Medical Director, Acute Hematology Care Unit
  Children's Hospital of Philadelphia, Philadelphia, PA, USA
  Philadelphia, Pennsylvania, United States
• AI

  Adlette Inati, MD, FAAP

  Professor of Clinical Medicine
  Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Department of Pediatrics and Adolescent Medicine, Beirut, Lebanon
  Tripoli, Liban-Nord, Lebanon
• BI

  Baba PD Inusa, MD

  Medical Doctor
  Department of Paediatric Haematology, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust
  London, England, United Kingdom
• MA

  Miguel R. Abboud, MD

  Professor and Chairman
  American University of Beirut Medical Center, Beirut, Lebanon
  Beirut, Beyrouth, Lebanon

Poster Presenter(s)

• 

  Beng Fuh, MD

  Professor of Pediatrics
  East Carolina University, Brody School of Medicine
  Greenville, North Carolina, United States

  Slides

Author(s)

• RK

  Ramasubramanian Kalpatthi, MD

  Clinical Research Director
  Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
  Pittsburgh, Pennsylvania, United States
• PT

  Paul Telfer, MD

  Royal London Hospital
  Barts Health NHS Trust
  London, England, United Kingdom
• ST

  Sara Trompeter, MD

  Medical Doctor
  University College London NHS Foundation Trust, London, UK
  London, England, United Kingdom
• SD

  Sandy Dixon, MS

  Biostatistician
  Pfizer Inc, South San Francisco, CA, USA
  South San Francisco, California, United States
• AE

  Aimee Enriquez, n/a

  Sr. Clinical Trial Manager
  Pfizer Inc, South San Francisco, CA, USA
  South San Francisco, California, United States
• FA

  Fatemeh Akhlaghi, PharmD, PhD

  Clinical Pharmacology
  Pfizer Inc, South San Francisco, CA, USA
  South San Francisco, California, United States
• KS

  Kim Smith-Whitley, MD

  Medical Doctor
  Children's Hospital of Philadelphia, Philadelphia, PA, USA & Pfizer Inc, South San Francisco, CA, USA
  South San Francisco, California, United States
• CB

  Clark Brown, MD, PhD

  GPD
  Children's Healthcare of Atlanta, Atlanta, GA, USA & Pfizer Inc, South San Francisco, CA, USA
  South San Francisco, California, United States